Loading...
Docoh

322 results

Filter options loading...
Top filers
Top filing types
Recent filing years
10-Q
2022 Q1
OTLC Oncotelic Therapeutics, Inc.
23 May 22
Quarterly report
6:20am
financing arrangements are in place at this time. If the Company is unable to access additional funds when needed, it may not be able to continue … . Additional debt financing, if available, may involve restrictive covenants and could also be dilutive. The Company’s ability to access capital
424B3
OTLC Oncotelic Therapeutics, Inc.
11 May 22
Prospectus supplement
5:10pm
may not have access to the full $10,000,000 amount of the Equity Purchase Agreement. Before you invest in our Common Stock, you should carefully … and certain insiders. If we are unable to access additional funds in the near term, whether through the sale of additional equity, debt or another means
POS AM
OTLC Oncotelic Therapeutics, Inc.
26 Apr 22
Prospectus update (post-effective amendment)
5:01pm
speculative. We may not have access to the full $10,000,000 amount of the Equity Purchase Agreement. Before you invest in our Common Stock, you should … by officers and certain insiders. If we are unable to access additional funds in the near term, whether through the sale of additional equity, debt
10-K
2021 FY
OTLC Oncotelic Therapeutics, Inc.
15 Apr 22
Annual report
4:26pm
additional capital, we would seek to further develop our product candidates. However, our inability to access capital historically has and may … insiders. If we are unable to access additional funds in the near term, whether through the sale of additional equity, debt or another means, we may
8-K
EX-99.1
OTLC Oncotelic Therapeutics, Inc.
13 Apr 22
Letter to Oncotelic Shareholders on the Recently Completed Joint Venture Transaction with Dragon Overseas Capital Limited
11:56am
for pediatric cancer which give us access to the RPD voucher on top of the regulatory exclusivity reserved for ODD while we continue strategic
8-K
EX-10.1
3meqq0v2aod3uuxp 6i
1 Dec 21
Entry into a Material Definitive Agreement
4:08pm
10-Q
l13azycgxsk5
22 Nov 21
Quarterly report
5:00pm
8-K
EX-10.1
df2l5f7f
4 Oct 21
Entry into a Material Definitive Agreement
7:15am
10-Q
fwi1exa gfa90tm
20 Aug 21
Quarterly report
4:31pm
424B3
e56rfz5uuk
3 Jun 21
Prospectus supplement
1:00pm
S-1
bdxjqnk8d68bwrz7cp
24 May 21
IPO registration
5:26pm
10-Q
7k7gurc xkaa
24 May 21
Quarterly report
4:16pm
8-K
EX-10.1
evj0x
7 May 21
Entry into a Material Definitive Agreement
5:00pm
10-K
qgommqx8
15 Apr 21
Annual report
5:01pm
8-K
EX-10.1
hm7p mkzfjw
26 Mar 21
Entry into a Material Definitive Agreement
5:06pm
8-K
eck 3qgy4r
18 Feb 21
Other Events
8:27am
8-K
EX-99.1
w9cvy643y
2 Feb 21
Mateon Launching Mobile App, Artihealth™, for Remote Respiratory Health Assessment
4:30pm
8-K
EX-99.1
9qvruglhwqu iet96d
1 Feb 21
Other Events
1:49pm
8-K
bsawbgnrbt5vx
1 Feb 21
Other Events
1:49pm
10-Q
EX-10.57
7mr8cg5ipcz37d
16 Nov 20
Quarterly report
6:42am